Abnormal/unsteady gait Underpinning Sciences Basic Medical Sciences Structure and function of CNS, spinal cord and peripheral nerves particularly motor and extra pyramidal systems. Control mechanisms within nervous system. Biochemistry of nervous system function and dysfunction. Factors effecting development of nervous system. Physiology of nerve conduction. Functional anatomy and blood supply of brain and spinal cord. Understand role neuro-transmitters in CNS. Understand control of voluntary movement. Understand upper and lower motor neurone pathologies. Clinical Sciences Pathophysiology of upper/lower motor neurone disorders; disorders of extra pyramidal system and cerebellum; disorders of muscles and peripheral nerves. Features of spinal cord disorders and compression. Developmental milestones in children. Understand upper and lower motor neurone pathologies. Behavioural Sciences Factors underlying non-organic causes. Population Health Sciences Screening of CDH. Epidemiology of common neurological causes (e.g. stroke, MS, cerebral palsy). NSF for falls in the elderly. Index Conditions Common or less common but dangerous Stroke. Childhood hip disorders. Parkinsons disease. Cerebral palsy. Multiple sclerosis. Spinal cord compression. Joint disorders. Uncommon but illustrative Cerebellar disorders. Peripheral neuropathies. Myopathies/Dystrophies Non-organic causes Spinal cord disorders (e.g. Guillain Barre Syndrome, polio). Motor neurone disease Structure and function of CNS, spinal cord and peripheral nerves The brain is divided into 2 halve, which are connected in the midline by the corpus callosum and the anterior and posterior commissures (which are anterior and posterior to the callosum). Each of the hemispheres in then divided into 4 lobes frontal, parietal, temporal and occipital, so named after the overlying bones. The hemispheres are composed of grey matter (peripherally) and white matter (centrally). Anywhere within the cerebral hemispheres where there is a density of grey matter is called a nucleus. Examples of these are the thalamus, caudate nucleus. These are areas where neurones are synapsing in significant density, these are surrounded by white matter in the brain, where myelinated neurones are passing in between centres of the brain. Glutamate is the major excitatory neurotransmitter in the CNS, whereas GABA is the main inhibitory neurotransmitter in the CNS. The spinal cord is the opposite of the brain with the grey matter (area of all the synapses) is in the centre of the cord and the white matter on the periphery of the cord. The sensory information leaves the cord posteriorly through the posterior root, the cell bodies are in the dorsal root ganglion outside of the cord, these join the anterior roots to form the spinal nerve. There are also grey and white rami which leave/enter the spinal cord and communicate with the sympathetic chain. The motor system is carried in the anterior part of the spinal cord, the main one of these is the corticospinal tract, but there are others, for example the reticulospinal tract and the rubrospinal tract. The corticospinal tract is involved in the control of voluntary movement, the others are involved in things like posture control head movements. The corticospinal tracts start in the motor cortex in the posterior frontal lobe, and they commence from layer 5 of the cortex from the Betz cells. They run down from the cortex, through the reticular formation and the internal capsule and then synapse with various nuclei in the brain (e.g. the basal ganglia and the cerebellum), for coordination of the movement. The corticospinal tract mostly (85%) decussates in the medulla (pyramids) forming the lateral corticospinal tract, although 15% remains uncrossed and forms the anterior corticospinal tract. Organisation of the motor system (3 main): 1. The corticospinal (or pyramidal) system originates in the frontal lobe in the cortex and delivers information to spinal cord anterior horn cells. This is the system which allows purposeful, skilled, intricate, strong and organised movement to occur. Defective function of this system leads to loss of skilled movements, spasticity and reflex change. This is seen in hemiplegia. 2. The extrapyramidal system facilitates fast, fluid movements that the corticospinal system has generated. Defective function is recognised usually by slowness (bbadykinesia), stiffness (rigidity) and/or disorders of movement (rest tremor, chorea and other dyskinesias). Frequently, one sign (e.g. stiffness, tremor or chorea) will predominate. Mixtures of these features, and lack of localised pathological anatomy makes classification difficult. 3. The cerebellum and its connections have a role in coordinating smooth movements initiated by the corticospinal system, and the regulation of balance. Cerebellar disease leads to unsteadiness and jerkiness of movement (ataxia), with characteristic physical signs of past pointing, action tremor and incoordination. Each of these three motor controllers also relies upon connections with the other two, and with sensory input, from proprioception, reticular formation, vestibular system and special senses. Characteristics of pyramidal/UMN lesions: weakness, spasticity (remember acutely the limbs may be flaccid and tendon reflexes lost- then becomes spastic with claspknife effect), changes in superficial reflexes (extensor plantar response, cremasteric reflex lost), drift of an upper limb (downward, medially, with pronation and finger flexion), weakness and loss of a skilled movement (if above decussation= contralateral to the lesion- in the upper limb flexors remain stronger, the lower limbs the extensors remain stronger), muscle wasting is not a feature and have normal electrical excitability. There are 2 main patterns of UMN lesions, hemiparesis (brain lesion) and paraparesis (spinal cord lesion): Hemiparesis= o Motor cortex: weakness and/or loss of skilled movement confined to one contralateral limb or part of a limb is typical of an isolated motor cortex lesion (e.g. a secondary neoplasm) a defect in higher cortical function and focal epilepsy may occur o Internal capsule: since all the fibres are tightly packed, a small lesion causes a large deficit, and may cause a sudden, dense, contralateral hemiplegia o Pons: rarely only confined to the corticospinal tract, may have localising signs e.g. 6th or 7th nerve lesions. o Spinal cord: would cause an ipsilateral lesion, there may be presence of Brown-Sequard syndrome. Paraparesis= o Bilateral damage of the corticospinal tracts, may be due to spinal cord compression, but cerebral disease may cause paraparesis (e.g. midline skull vault meningioma). Extrapyramidal system: Refers to the basal ganglia i.e. corpus striatum (caudate nucleus, globus pallidus and putamen), subthalamic nucleus, substantia nigra and parts of the thalamus. Extrapyramidal disorders are classified broadly into akinetic-rigid syndromes (in which poverty of movement predominates) and dyskinesias (where there are various involuntary movements). The most common extrapyramidal disorder is Parkinson’s disease. In many involuntary movement disorders there are substantial and specific changes in neurotransmitters, rather than anatomical lesions. The main neurotransmitters in the extrapyramidal system are dopamine, GABA, norepinephrine, serotonin, GAD (glutamic acid decarboxylase), acetylcholine. Cerebellum: This modulates coordination rather than speed. Ataxia is characteristic when it malfunctions. The cerebellum receives afferent fibres from: Proprioceptive receptors in joints and muscles Vestibular nuclei Basal ganglia The corticospinal system Olivary nucleus Efferent fibres pass from the cerebellum to: Each red nucleus Vestibular nuclei Basal Ganglia Corticospinal system. Each ipsilateral cerebellar lobe coordinates movement of the ipsilateral limbs. The vermis (a midline structure) is concerned with maintenance of axial (midline) posture and balance. Lesions in the lateral lobes of the cerebellum cause ipsilateral symptoms with problems of posture and gait, tremor and ataxia, nystagmus, dysarthria, other signs (titubation- rhythmic head tremor, hypotonia, depression of reflexes). Midline cerebellar lesions affect the truncal muscles with difficulty standing unsupported and a rolling, broad, ataxic gait. Lesions of the flocculonodular region of the cerebellum cause vertigo, vomiting and gait ataxia. Physiology of nerve conduction The nerve relies on action potentials to transmit information. This is reliant on sodium and potassium movement into and out of the cells. The resting potential of the neuron is normally around -65- -75mV. This is altered when the action potential is initiated and the sodium channels are opened and sodium enters the cell, making the potential less negative. As the potential becomes negative, this causes voltage-gated potassium channels to open. The action potential will reach a potential of around +35-40mV. This is when depolarisation along the nerve occurs. As this depolarisation causes the sodium channels around the site to also become depolarised, and the action potential is transmitted along the nerve. If the nerve is myelinated, then this means the action potential has to ‘jump’ along the nerve in between the myelin sheaths (the gaps are the nodes of Ranvier) and this type of nerve transmission is Saltatory conduction. When the nerve reaches the pre-synaptic terminal, the transmission of the action potential would stop unless there is some way to transfer the potential to the postsynaptic bulb. This is allowed with by the use of neurotransmitters. When the action potential reaches the terminal bulb, calcium channels open in the bulb and calcium therefore influxes into the cell. These then bind to vesicles in the neurone, which then move to fuse with the cell membrane and are released into the junction between the pre-and post-synaptic bulb. The neurotransmitters then join with receptors at the post synaptic membrane, and open sodium channels to allow potentiation along the postsynaptic neurone. Upper and Lower motor neurone lesions Upper motor neurone: The lesion is anywhere above the anterior horn cell. The signs of this lesion is that everything goes up (up going plantars-extensor, brisk reflexes, increased muscle tone and no muscle wasting). Lower motor neurone: This is the converse of the above, so the lesion is everything below the level of the anterior horn cell including the muscles. The signs of this is that everything goes down (muscle wasting, no reflexes, flaccid tone, fasciculations, trophic skin and nail changes). Difficulty walking and falls Change in gait is a common presenting complaint in neurology. Arthritis and muscle pains also alter gait, making walking stiff and slow (antalgia). Falls, especially in the elderly, are a common cause of morbidity. The pattern of abnormal gait is valuable diagnostically. Spasticity: more pronounced in extensor muscles, with or without weakness, causes walking to be stiff and jerky. Toes of shoes become scuffed, catching level ground. Pace is shortened an narrow base maintained. Clonus may be noticed. When the problem is predominantly unilateral and weakness is marked (in a hemiparesis), the stiff weak leg drags and is circumducted. Parkinson’s: Muscular rigidity throughout extensor and flexor muscles, power is preserved but walking slows. The pace shortens and is shuffling with a narrow base. The patient becomes stooped and diminished arm swinging is seen. Gait becomes festinate, with small rapid steps, with the patient tripping over themselves. Retropulsions= small backward steps taken involuntarily when a patient is halted. Cerebellar Ataxia: disease of the lateral cerebellar lobes, stance is broad based and unstable and tremulous. Walking tends to veer towards the more affected cerebellar lobe. If disease is only in the midline then only the trunk will be ataxic, with the arms and legs unaffected. Sensory Ataxia: broad high-stepping gait is seen in peripheral neuropathy due to loss of proprioception. Ataxia is worsened by the removal of additional sensory input- see in positive Romberg’s test. Lower limb weakness: in distal weakness, the leg must be lifted over obstacles. If dorsiflexors are weak e.g. in common peroneal nerve palsy, the feet return to the ground with a slapping sound. In proximal weakness (e.g. polymyositis, muscular dystrophy) leads to difficulty in rising from sitting and climbing stairs. When walking the patient may have a waddling gait, as the hip muscles are weak and therefore it is unstable. Gait apraxia: with frontal lobe disease (e.g. tumour, hydrocephalus, infarction), the acquired skill of walking becomes disorganised. Leg movement is normal when sitting or lying but initiation and organisation of walking fail. This is gait apraxia a failure of the skilled act of walking. Shuffling small steps, difficulty initiating walking or undue hesitancy may predominate. Urinary incontinence and dementia are often present with frontal lobe disease. Falls: especially in the elderly can be problematic-e.g. following hip or upper limb fracture. Often no cause can be found. An MDT approach is necessary e.g. reviewing risk factors and need for home aid. Features of spinal cord disease and compression The cord extends from C1 to the vertebral body of L1 where it becomes the conus medullaris. Principle features of chronic and subacute cord compression are spastic paraparesis or tetraparesis, radicular pain at the level of compression and sensory loss below the compression. For example, in compression at T4 a band of pain radiates around the thorax, characteristically worse on coughing and straining. Spastic paraparesis develops over months, days or hours, depending upon the underlying pathology. Numbness commencing in the feet rises to the level of compression, this is the sensory level. Urinary retention and constipation develop. Cord compression is a medical emergency, it is sometimes hard to spot as pain may be absent. Causes of spinal cord compression: Spinal cord neoplasms Epidural haemorrhage Disc and vertebral lesions Rarities o Chronic degenerative o Paget’s disease, o Trauma scoliosis, epithelial endothelial and parasitic Inflammatory cysts, aneurysmal bone o Epidural abscess cyst, vertebral angioma, o Tuberculosis haematomyelia, o Granuloma arachonoiditis, Vertebral neoplasms osteoporosis, AVM. o Metastasis o Myeloma Spinal cord neoplasms Pathophysiology of upper and lower motor neurone diseases The commonest cause of an upper motor neuron lesion is a stroke, where the lesion is most commonly in the motor cortex of the brain, but can also be in the internal capsule, medulla or spinal cord. Multiple sclerosis causes upper motor neuron lesions if a plaque develops in the motor system. Multiple sclerosis does not cause a lower motor neurone lesion as the plaques only occur in the CNS. These symptoms may be transient, in the acute episode of inflammation, and may fully recover, however some motor deficit may remain following this acute attack leading to chronic disability. Other upper motor neuron causes might be motor neuron disease, and this can exclusively affect the upper motor neurons in Primary lateral sclerosis. There is a progressive tetraparesis with terminal pseudobulbar palsy. This is a progressive degenerative disease. Another cause could be a spinal cord compression, of any of the causes listed above. Tumours in the CNS may also be a cause of a motor neuron disorder, a syrinx (fluid filled cavity) in the cervical or thorax cord. Metabolic and toxic cord diseases: Vitamin B12 deficiency, Lathyrism, Acute transverse myelopathy, anterior spinal artery occlusion and radiation myelopathy are all very rare caused of upper motor neuron diseases. In order to localise the lesion to a part of the nervous system, it is important to look at the other symptoms present. Lower motor neuron diseases are anywhere downward from the anterior horn cell, and this includes the neuro-muscular junction and the muscles. At the level of the cranial nerve nuclei and anterior horn cell: Bell’s palsy, motor neurone disease, poliomyelitis. At the level of the spinal root: cervical and lumbar disc protrusion, neuralgic amyotrophy. At the level of the peripheral (or cranial) nerve: nerve trauma or entrapment, mononeuritis multiplex (lesion in the vasa nervorum). At the level of the motor end plate (NMJ): myasthenia gravis, Eaton-Lambery syndrome At the level of the muscle: myopathies and muscular dystrophies. Screening for CDH (or DDH) and its management DDH is a spectrum of disorders ranging from dysplasia to subluxation through frank dislocation of the hip. Early detection is important as it usually responds to conservative treatment; late diagnosis is usually associated with hip dysplasia which requires complex treatment often including surgery. Neonatal screening is performed as part of the routine examination of the newborn, by checking if the hip can be dislocated posteriorly out of the acetabulum (Barlow’s manoeuvre) or can be relocated back into the acetabulum on abduction (Ortolani’s manoeuvre). REMEMBER AS BARLOW’S MANOEUVRE IS PUSHING THE LEG BACKWARDS. These tests are repeated at routine surveillance at 8 weeks of age. Thereafter, presentation of the condition may be with detection of asymmetry of the hip, shortening of the affected leg or limp or abnormal gait. On screening a hip abnormality is detected in about 6-10 per 1000 live births. The true prevalence of DDH is about 1.5 per 1000, clinical neonatal screening misses some cases. If DDH is suspected, a specialist orthopaedic opinion should be obtained, an ultrasound performed and this allows detailed assessment of the hip, quantifying the degree of dysplasia and whether there is subluxation or dislocation. If the initial ultrasound is abnormal, the infant may be placed in a positioning device, which puts the hips in abduction (e.g. Craig splint), or in a restraining device (e.g. Pavlik harness) for several months. Progress needs to be monitored by ultrasound or X-ray. The splinting must be done expertly, as necrosis of the femoral head is a potential complication. If all conservative measures fail then open reduction and derotation femoral osteotomy will be required if conservative measures fail. Other hip conditions in children: Transient synovitis: most common cause of acute hip pain in children. Occurs in the ages 2-12 years and often follows or accompanies a viral infection. Presents with a sudden onset of hip pain or limp, no pain at rest but decreased range of movement, particularly external rotation. Child does not appear ill, and blood cultures are negative. Management is with bed rest and sometimes skin traction. Perthes disease: due to ischaemia of the femoral epiphysis, resulting in avascular necrosis, followed by revascularisation and reossification over 18-36 months, it mainly affects boys (5:1) of 5-10 years old. Presentation is insidious with the onset of limp or hip pain. The condition may be initially mistaken for transient synovitis. It is bilateral in 10-20%. X-ray shows increased density in the femoral head, but it may be normal, the patient may require a bone scan or MRI. In most the prognosis is good (best is in <6 years with < half the femoral head controlled.) If over 6 with more damage then the child risks degenerative arthritis in adult life. Management is with bed rest and traction, in more severe disease the femoral head needs to be covered by the acetabulum to act as a mould for the reossifying epiphysis. This is achieved by maintaining the hip in abduction with plaster or calipers or by performing femoral or pelvic osteotomy. Slipped upper femoral epiphysis: there is displacement of the epiphysis of the head postero-inferiorly. It is most common at 10-15 years during the adolescent growth spurt, particularly in obese boys. Presentation is with limp or hip pain, which may be referred to the knee. There is restricted abduction and internal rotation of the hip. The onset may be acute, following minor trauma. In 20% it is bilateral. The diagnosis is confirmed on X-ray. The management is surgical, usually with pin fixation in situ. Severe slips may require subsequent corrective realignment osteotomy once the epiphysis has fused or, rarely, open reduction of the hip, but this carries a risk of avascular necrosis. Septic arthritis: This is the opposite to transient synovitis, there is sudden onset of hip pain or limp. The affected joint may be red and swollen and hot to the touch. There may be a detectable effusion. The child will appear unwell and may have a systemic temperature. The child will hold the limb still and refuse passive movement. In up to 15% there is associated osteomyelitis. The white cell count will be increased and acute-phase reactants. Ultrasound is helpful to identify an effusion. X-rays are initially normal, apart from widening of the joint space and soft tissue swelling. Aspiration of the effusion under ultrasound for culture will give the definitive diagnosis. Management is with a prolonged course of antibiotics, usually IV (e.g. flucloxacillin combined with a third-generation cephalosporin to cover H. influenzae). Joint wash out or surgical drainage may be required. Usual organisms= Staph. aureus and H. influenzae prior to Hib vaccination. Osteomyelitis: may present with hip pain Juvenile idiopathic arthritis: may cause hip pain, presenting with persistent joint swelling presenting before 16 years of age in the absence of infection or a defined cause. Newly presenting JIA is rare. It has a prevalence of 1 in 1000 children. There are at least 7 different forms of the disease. Complications of these are: chronic anterior uveitis, flexion contractures of the joints, growth failure, amyloidosis (causing proteinuria and subsequent renal failure). Management is with NSAIDs, intra-articular steroids, systemic steroids, DMARDs (methotrexate is effective in 70% of children), and biological if not controlled by methotrexate. Cerebral Palsy Definition: is a disorder of movement and posture due a non-progressive lesion of motor pathways in the developing brain. Although the lesion is non-progressive, the clinical manifestations emerge over time, reflecting the difference between normal and abnormal cerebral maturation. Cerebral palsy is the most common cause of motor impairment in children, affect 2 per 1000 live births. Children with cerebral palsy often have other problems reflecting more widespread brain dysfunction: Learning difficulties Epilepsy Squints Visual impairment Hearing impairment Speech and language disorders Behavioural disorders Feeding problems Joint contractures, hip subluxation, scoliosis. Cause of CP: 80% is antenatal in origin: vascular occlusion, cortical migration disorders or structural maldevelopment of the brain during gestation, some problems are linked to gene deletions, congenital infection 10% are due to hypoxic-ischaemic injury at birth. 10% postnatal in origin. Pre term infants are especially vulnerable to brain damage from periventricular leukomalacia secondary to ischaemia and/or severe intraventricular haemorrhage. Other postnatal causes are infection (meningitis, encephalitis, encephalopathy from brain trauma, symptomatic hypoglycaemia, hydrocephalus and hyperbilirubinaemia. Check for clotting disordered in neonatal stroke. There are 3 main types of CP spastic (70%), ataxia hypotonic (10%), dyskinetic (10%) and there may be a mixed pattern (10%). This can be thought of as cortical, basal ganglia and cerebellar patterns. There is nothing medical that can be given to manage CP, it is important the parents are made aware of the nature of the disease and that there is an MDT approach to assessment and management. It is an important cause of missed milestones in childhood. Parkinson’s Disease In the pars compacta of the substania nigra, progressive cell degeneration and neuronal eosinophilic inclusion bodies (Lewy bodies) are seen. These contain protein filaments of ubiquitin and alpha-synulcein. Degeneration also occurs in other basal ganglia nuclei. Biochemically there is loss of dopamine (and melanin) in the striatum. This correlates well with cell loss and with the degree of akinesia. Symptoms: combination of tremor, rigidity and akinesia develops slowly, over several months or years, together with changes in posture. The most common initial symptoms are tremor and slowness. Patients may complain of stiffness in the limbs and joints. Fine movements become difficult and slowness causes characteristic difficulty in rising from a chair or getting in/out of bed. There is micrographia (small and spidery writing), and tends to tail off. It is almost always initially more prominent on one side. Signs: Tremor= 4-7Hz pill-rolling tremor at rest, decreasing with action. Rigidity= stiffness throughout range of movement, and equal in opposing muscle groups. There is ‘lead pipe’ increase in tone- usually more marked on one side. It is also present in the neck and axial muscles. When stiffness occurs with tremor, smooth ‘lead pipe’ rigidity is broken up into a jerky resistance to passive movement- known as cogwheeling. Akinesia= poverty and slowing of movement (bradykinesia) is an additional handicap, distinct from rigidity. There is difficulty initiating movement. Rapid fine finger movements e.g. piano-playing, become indistinct, slow and tremulous. Facial immobility gives a mask-like semblance of depression. The frequency of spontaneous blinking is reduced. Postural changes= a stoop is characteristic. Gait becomes, hurrying (festinant) and shuffling with poor arm swinging. Balace deteriortates, falls are common. Speech= pronunciation is initially a monotone but progresses to characteristic tremulous slurring dysarthria, the result of combined akinesia, tremor and rigidity. Speech may eventually be completely lost. GI and other symptoms= include heartburn, dribbling, dysphagia, constipation and weight loss. Urinary difficulties are common, especially in men. Skin is greasy and sweating excessive. Natural History: worsens over years, beginning as a mild inconvenience but slowly progressing. Remissions are unknown except for rare and remarkable short-lived periods of release. These tend to occur at times of great emotion, fear or excitement, when the sufferer is released for seconds or minutes and able to move quickly. While bradykinesia and tremor worsen, power remains normal until immobility makes its assessment difficult. Patients often complain bitterly of limb and joint discomfort. There is no sensory loss, reflexes are brisk. Cognitive function is preserved early on, dementia often develops in the late stages. Anxiety and depression are common. Usually the course is over 10-15 years, with death resulting from bronchopneumonia. Treatment: No drugs alter the course of PD, levodopa and/or dopaminergic agonists produce striking initial symptomatic improvement. Avoid drugs until clinically necessary because of delayed unwanted effects. Catechol-O-methyl transferase inhibitors are also used as supplementary therapy. Selegeline, a monoamine oxidase B inhibitor, may delay the need for levodopa therapy by some months. Antioxidants are also used, but their value is unproved. Levodopa is combined with an aromatic amino acid decarboxylase inhibitorbenserazide (Madopar) or carbidopa (Sinemet), reduces the peripheral side-effects, principally nausea, of levodopa and it’s metabolites. Levodopa is commenced and gradually increased. The great majority of patients with idiopathic PD improve initially with levodopa. The response in severe, previously untreated idiopathic PD is sometimes dramatic. Unwanted effects= nausea and vomiting, confusion, formed visual pseudo-hallucinations and chorea also occur. There are difficult issues with long-term therapy (levodopa induced involuntary movements). After several years levodopa gradually becomes ineffective, even with increasing doses. As treatment continues, episodes of immobility develop (freezing). Falls are common. Fluctuation in response to levodopa also appears, its effect apparently turning ‘on and off’, causing freezing alternating with dopa-induced dyskinesias, chorea and dystonic movements. Levodopa’s duration of action shrinks, with dyskinesia become several hours after a dose. The patient also begins to suffer from a chronic levodopa-induced movement disorder. Approaches to treatment of these complications include: Shortening the interval between levodopa doses and increasing each dose Selegiline, a type B monoamine oxidase inhibitor, inhibits catabolism of dopamine in the brain. This sometimes smooths out the selegeline response. Dopaminergi c agonists are added, or replace levodopa Entacapone is used Drug holidays are occasionally helpful . Dopamine receptor agonists: Bromocriptine, lisuridem pergolide, cabergoline (ergot derivatives), pramipexole and ropinerole are oral directly acting dopamine receptor agonists, acting principally on D1 and D2 receptors. The ergot derivatives are associated with retroperitoneal and pericardial fibrotic reactions. Apomorphine, a potent D1 and D2 agonist given by subcutaneous metered infusion is an effective method of smoothing out fluctuations in response to levodopa. Vomiting is common with apomorphine, and haemolytic anaemia is an unusual side-effect. DRA are in general less effective than levodopa, but cause fewer late unwanted dyskinesias. Stereotactic neurosurgery: used less frequently with newer drugs but still improves tremor and dyskinesia. Thalamic stimulation is used. Physiotherapy and physical aids. Multiple Sclerosis MS is a chronic inflammatory disorder of the CNS. There are multiple plaques of demyelination within the brain and spinal cord. Plaques are ‘disseminated in time and place’, hence the old name disseminated sclerosis. Plaques of demyelination, initially 2-10mm in size are the cardinal feature. Plaques are perivenular with a predilection for distinct CNS sites: optic nerves, the periventricular region, brainstem and it’s cerebellar connections and the cervical spinal cord (corticospinal tracts and posterior columns). Acute relapses are caused by focal inflammatory demyelination, which causes a conduction block. Inflammation induces local production of nitric oxide by macrophages, which damages central nerve fibres. Remission follows as inflammation subsides. Remyelination occurs and helps recovery. When damage is severe, secondary permanent axonal destruction occurs. In the cord, plaques rarely destroy large groups of anterior horn cells- thus focal muscle wasting (e.g. small hand muslces) is unusual. MS plaques are not seen in myelin sheaths of peripheral nerves. Clinical Features: The commonest age of onset is between 20 and 45 years, a diagnosis before puberty or after 60 years is rare. MS is more common in women. No single group of signs or symptoms is absolutely diagnostic. Despite this, MS is often recognisable clinically by different patterns: Relapsing and remitting MS (80-90%) Primary progressive MS (10-20% of cases) Secondary progressive MS- this follows on from relapsing-remitting disease Occasionally (10%) MS runs a fulminating course over some months (fulminant MS). Presentation which would cause a change in the gait would be from a lesion in the spinal cord which might cause a spastic paraparesis developing over days or weeks and is typically a result of a plaque in the cervical or thoracic cord, causing difficulty in walking and numbness. Lhermitte’s sign may be present. Urinary symptoms are common. Brainstem demyelination commonly causes combinations of diplopia, vertigo, facial numbness/weakness, dysarthria or dysphagia. Pyramidal signs in the limbs occur when the corticospinal tracts are involved (greater weakness in the extensors of the lower limb). Management: none medical= practical advice at work, on walking aids, wheelchairs, car conversions, alterations to houses and gardens is needed, from professionals with experience of rehabilitation. Wide-ranging support- for fear, reactive depression and sexual difficulties- is also helpful. MDT liaison between patient, carers, doctors and therapists is essential. Treat all infections. Urinary infection frequently exacerbates symptoms. Physiotherapy is of particular value in reducing pain and discomfort of spasticity, particularly lower limb flexor spasms. Muscle relaxants (e.g. baclofen, BDZs, dantrolene and tizanidine) are sometimes helpful. Injected botulinum toxin is used for painful spasms. Prevention of pressure sores is vital.